We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

307 hedge funds and large institutions have $8B invested in CUBIST PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 66 increasing their positions, 90 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

483% more funds holding in top 10

Funds holding in top 10: 6 → 35 (+29)

82% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 68

51% more capital invested

Capital invested by funds: $5.31B → $8B (+$2.69B)

21% more funds holding

Funds holding: 254 → 307 (+53)

27% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 90

54% less call options, than puts

Call options by funds: $329M | Put options by funds: $708M

Holders
307
Holders Change
+53
Holders Change %
+20.87%
% of All Funds
8.19%
Holding in Top 10
35
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+483.33%
% of All Funds
0.93%
New
124
Increased
66
Reduced
90
Closed
68
Calls
$329M
Puts
$708M
Net Calls
-$379M
Net Calls Change
-$371M

Top Buyers

Rank Fund Capital Flow
1
HI
HBK Investments
Texas
+$222M
2
PCM
Pentwater Capital Management
Florida
+$201M
3
FCM
Farallon Capital Management
California
+$199M
4
EPCM
Eton Park Capital Management
New York
+$148M
5
DKCM
Davidson Kempner Capital Management
New York
+$127M

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$477M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$312M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$280M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$250M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$156M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$78.9M +$58.2M +748,835 +2,162%
GP
27
GLG Partners
United Kingdom
$77.3M +$59.7M +767,613 New
AQR Capital Management
28
AQR Capital Management
Connecticut
$76.5M +$58.4M +751,354 +8,636%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$72.7M -$280M -3,605,622 -83%
GF
30
Gabelli Funds
New York
$65.6M +$44.3M +569,500 +695%
JP Morgan Chase
31
JP Morgan Chase
New York
$65M +$39.4M +507,315 +365%
WCMNY
32
Westchester Capital Management (New York)
New York
$65M +$50.2M +646,255 New
AIM
33
Allen Investment Management
New York
$61.4M +$47.4M +610,276 New
PRCM
34
Pine River Capital Management
Minnesota
$61M +$37.6M +483,937 +397%
Northern Trust
35
Northern Trust
Illinois
$60.9M -$1.92M -24,698 -4%
UOC
36
UBS O'Connor
Illinois
$59.7M +$46.1M +592,729 New
BlackRock
37
BlackRock
New York
$58.6M +$44.1M +566,919 +3,610%
EM
38
Elliott Management
New York
$54.3M +$41.9M +539,000 New
Norges Bank
39
Norges Bank
Norway
$52.8M +$7.83M +100,658 +24%
Barclays
40
Barclays
United Kingdom
$51.6M +$28.2M +362,588 +236%
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$47.5M +$36.7M +472,320 New
Morgan Stanley
42
Morgan Stanley
New York
$47.3M -$12.4M -159,611 -25%
CC
43
Carlson Capital
Texas
$46.6M +$36M +462,500 New
CC
44
Coastland Capital
California
$44.6M +$29.5M +379,704 +594%
TCA
45
Taconic Capital Advisors
New York
$40.3M +$31.1M +400,000 New
Geode Capital Management
46
Geode Capital Management
Massachusetts
$40M +$793K +10,196 +3%
Adage Capital Partners
47
Adage Capital Partners
Massachusetts
$39.8M +$30.7M +395,138 New
AAM
48
AMI Asset Management
California
$37.8M +$775K +9,974 +3%
CCMU
49
Cheyne Capital Management (UK)
United Kingdom
$37.6M +$29M +373,372 New
AIMCA
50
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$37.2M -$8.89M -114,290 -24%
1
2
3 4 5

CBST Hedge Fund Activity: Q4 2014 in Review

307 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q4 2014, worth a combined $8B — up 51% from $5.31B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new CBST positions and 68 closed out — a net gain of 56 holders — while 66 added to existing stakes and 90 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $222M. The largest seller was Putnam Investments, cutting an estimated $477M.

  • 307 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q4 2014, up from 254 in Q3 2014.
  • Funds reported $8B of CUBIST PHARMACEUTICALS INC stock for Q4 2014, up 51% quarter-over-quarter.
  • 124 funds opened new CUBIST PHARMACEUTICALS INC positions in Q4 2014 and 68 closed out, a net change of +56 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q4 2014 was HBK Investments, an estimated $222M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q4 2014 was Putnam Investments, an estimated $477M sold.

Based on aggregated 13F filings for Q4 2014.